关于 Dendreon Corporation

Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein. Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge. Source: Wikipedia
总部Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
成立2013
状态营业中

专利134 项专利

HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH…CA2923433C · 2020
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with…US10261091B2 · 2019
登录即可查看全部 134 项专利

浏览完整的专利组合,包括公开号、日期和同族专利。

登入 使用电子邮件创建账号

完全免费

在 Heelky 上搜索所有专利 →

评论

暂无评价。与 Dendreon Corporation 合作过?来第一个分享你的经历吧。

撰写评价 →

联系方式和链接

地点

Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US

这是你的公司吗?

免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。

认领此页面

分享此公司

Dendreon CorporationCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, UShttps://heelky.com/explore/companies/dendreon-corporation-q9lqmwsf/

复制链接

分享到

二维码

用手机相机扫描即可打开此页面,也可以下载用于传单、幻灯片或胸牌。

加入 Heelky,建立联系、招聘人才、实现成长

创建免费账户,即可给他人发消息、申请职位并发布任务。

立即加入 — 完全免费

选择语言

Heelky 会记住你的选择。

其他语言

可用语言:70 关于 Heelky 的语言